Market Currents
Elan (ELN) shares jump +4.6% premarket after Acorda Therapeutics (ACOR) announces positive...
-
Monday, August 1, 2011, 8:37 AM ETElan (ELN) shares jump +4.6% premarket after Acorda Therapeutics (ACOR) announces positive prescriber response for its AMPYRA treatment for MS patients. The drug is manufactured by Elan in a supply agreement with Acorda.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
